The Organon board of directors has approved the deal. The transaction is expected to close in the first quarter of 2026, subject to required regulatory approvals. “I am incredibly proud of the work ...

Organon & Co. OGN announced the completion of the divestiture of its JADA System to Laborie Medical Technologies Corp. The deal is worth up to $465 million, including $440 million paid at closing and ...

The acquisition expands Laborie's obstetrics portfolio and demonstrates the company's commitment to delivering innovative, proven solutions to physicians and patients globally. PORTSMOUTH, N.H., Nov.

Divesting seems to be one of the major trends in the medical device industry in 2025. Whether it's companies jettisoning spine offerings or moving away from diabetes, medtech companies are shedding ...

Laborie Medical Technologies Corp. secured a new gem for its maternal health with the acquisition of the Jada system from Organon & Co. The terms of the deal, first reported in November, included ...

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global women’s health company, today announced clearance by the U.S. Food and Drug Administration (FDA) of the Special 510(k) for ...

Thank you, operator, and good morning, everyone. Today, we will be referencing a presentation that is visible during this call for those of you on our webcast. This presentation will also be available ...

The MarketWatch News Department was not involved in the creation of this content. The acquisition expands Laborie's obstetrics portfolio and demonstrates the company's commitment to delivering ...